Lakewood-Amedex Biotherapeutics, Inc. carries a market capitalization of 3.29M, placing it among publicly traded companies globally.
| Market Cap | 3.29M |
| Enterprise Value | N/A |
Lakewood-Amedex Biotherapeutics, Inc.'s stock has declined approximately -97.82659% over the past 52 weeks. The 50-day moving average sits at 2.41, while the 200-day moving average is 9.75.
| Beta (5Y) | N/A |
| 52-Week Price Change | -97.82659% |
| 50-Day Moving Average | 2.41 |
| 200-Day Moving Average | 9.75 |
| Average Volume (20 Days) | N/A |
Lakewood-Amedex Biotherapeutics, Inc.'s most recent stock split took place on June 22, 2026 with a 10:1 split ratio.
| Last Split Date | 6/22/2026 |
| Split Ratio | 10:1 |